CordenPharma leases space at Flatiron Park for peptides development
CordenPharma Colorado will occupy the 5505 Central building under a 15-year lease.
Drug Development
Affinia receives FDA fast track designation for AFTX-201
Aspire Biopharma and Microsize collaborate for alprazolam powder formulation
Esperion to acquire Corstasis for cardiovascular franchise expansion
Rallybio to acquire Candid Therapeutics
Kairos Pharma signs deal for Celyn Therapeutics’ CL-273
Sanofi receives CHMP recommendation for Dupixent expansion in Europe
BioMarin receives FDA approval for Palynziq use in adolescents
